iRhythm Holdings (IRTC) EBIT Growth (1y) (2016 - 2026)
iRhythm Holdings (IRTC) EBIT Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 90.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 74.18% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -18.12% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | iRhythm Holdings | 3.50 Bn | 2.95 Bn | 141.35 Mn | 50.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.29% |
| Dec 31, 2025 | 155.99% |
| Sep 30, 2025 | 83.24% |
| Jun 30, 2025 | 18.59% |
| Mar 31, 2025 | 14.64% |
| Dec 31, 2024 | 89.58% |
| Sep 30, 2024 | -82.24% |
| Jun 30, 2024 | -21.77% |
| Mar 31, 2024 | 3.46% |
| Dec 31, 2023 | -89.30% |
| Sep 30, 2023 | -30.91% |
| Jun 30, 2023 | 19.53% |
| Mar 31, 2023 | 18.63% |
| Dec 31, 2022 | 35.72% |
| Sep 30, 2022 | 9.43% |
| Jun 30, 2022 | -38.01% |
| Mar 31, 2022 | -76.73% |
| Dec 31, 2021 | -236.07% |
| Sep 30, 2021 | -389.43% |
| Jun 30, 2021 | 15.72% |